Product Categories
| Country: | United States |
|---|---|
| Tel: | +86 (28) 8613-6736 / +86 15390448180 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan | C19H21ClFNO | 64169-45-5 | Details |
| Vildagliptin | C17H25N3O2 | 274901-16-5 | Details |
| Palonosetron Hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| (R)-3-Piperidinamine dihydrochloride | C5H13ClN2 | 334618-23-4 | Details |
| Sitagliptin phosphate | C16H15F6N5O.H3PO4 | 654671-78-0 | Details |
| ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) | C18H21N5O2 | 850649-61-5 | Details |
| (2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | C16H12F6N4O2 | 764667-65-4 | Details |
| Methyl 3-aMino-2-((2'-carbaMoylbiphenyl-4-yl)MethylaMino)benzoate | C22H21N3O3 | 147404-75-9 | Details |
| 5-BROMO-2-(2-METHYL-2H-TETRAZOL-5-YL)-PYRIDINE | C7H6BrN5 | 380380-64-3 | Details |
| 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene | C18H14FIS | 898566-17-1 | Details |
| N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C20H25N5 | 477600-73-0 | Details |
| (5R)-3-(3-FLUORO-4-IODOPHENYL)-5-HYDROXYMETHYLOXAZOLIDIN-2-ONE | C10H9FINO3 | 487041-08-7 | Details |
| Linagliptin | C25H28N8O2 | 668270-12-0 | Details |
| CROTONYLBETAINE(CARNITINE IMPURITY)(RG) | C16H30N2O6 | 927-89-9 | Details |
| Torezolid | C17H15FN6O3 | 856866-72-3 | Details |
| Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
| 2-Methylpyrazolo[1,5-a]pyriMidine-6-carboxylic acid | C8H7N3O2 | 739364-95-5 | Details |
| Valdecoxib IMpurity F | C16H12ClNO3S | 509074-26-4 | Details |
| Valdecoxib IMpurity B | C32H25N3O6S2 | 1373038-60-8 | Details |
| glycopyrronium bromide | C19H28NO3.Br | 475468-09-8 | Details |
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride | C6H7F3N4.ClH | 762240-92-6 | Details |
| 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine | C13H10ClN3O2S | 479633-63-1 | Details |
| (R,S)-Palonosetron Hydrochloride | C19H25ClN2O | 135755-51-0 | Details |
| rac-Sitagliptin | C16H15F6N5O | 823817-56-7 | Details |
| Anagliptin | C19H25N7O2 | 739366-20-2 | Details |
| (5-broMo-2-Methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)Methanone | C18H12BrFOS | 1132832-75-7 | Details |
| BOC-(S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID | C15H18F3NO4 | 922178-94-7 | Details |
| Esomeprazole sodium | C34H36MgN6O6S2 | 161796-78-7 | Details |
| GeMigliptin | C18H19F8N5O2 | 911637-19-9 | Details |
| (S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone | C10H10N2O4 | 14842-41-2 | Details |
| (-)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile | C20H23FN2O2 | 488787-59-3 | Details |
| (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine | C14H22N2 | 477600-69-4 | Details |
| 5-Methyl-3-phenyl-4-(phenylMethyl)isoxazole | C17H15NO | 139395-94-1 | Details |
| (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate) | C44H57FO9S | 1283129-18-9 | Details |
| (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine hydrochloride | C14H22N2.2(HCl) | 477600-68-3 | Details |
| (S)-Sitagliptin Phosphate | C16H16F6N5O5P | 823817-58-9 | Details |
| (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine | C14H22N2 | 1431697-80-1 | Details |
| Valdecoxib IMpurity-E | C16H11Cl2NO5S2 | 1373038-63-1 | Details |
| Sitagliptin DeaMino IMpurity 1 | C16H12F6N4O | 1253056-18-6 | Details |
| Methyl cyclopentylphenylglycolate | C14H18O3 | 19833-96-6 | Details |
| (S,R)-Palonosetron Hydrochloride | C19H25ClN2O | 135729-76-9 | Details |
| PidotiMod Diketopiperazine-6-propanoic Acid | C9H12N2O4S | 161771-75-1 | Details |
| 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | C16H20N6O | 1092578-48-7 | Details |
| BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID | C15H19F2NO4 | 269396-59-0 | Details |
| (3S,4S)-Tofacitinib | C16H20N6O | 1092578-47-6 | Details |
| (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine | C14H22N2 | 1354486-07-9 | Details |
| Valdecoxib | C16H14N2O3S | 181695-72-7 | Details |
| 2-(7-Methoxynaphthalen-1-yl)acetamide | C13H13NO2 | 138113-07-2 | Details |
| 2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile | C13H10ClN3O2 | 865758-96-9 | Details |
| 5-Methyl-3,4-diphenylisoxazole | C16H13NO | 37928-17-9 | Details |
| Escitalopram oxalate | C22H23FN2O5 | 219861-08-2 | Details |
| 1-methylpyrrolidin-3-yl cyclopentylphenylglycolate | C18H25NO3 | 13118-11-1 | Details |
| (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt | 2C20H23FN2O2.C20H18O8 | 128173-53-5 | Details |
| Saxagliptin | C18H25N3O2 | 361442-04-8 | Details |
| 1,3-dihydro-1-oxoisobenzofuran-5-carboxamide | C9H7NO3 | 85118-25-8 | Details |
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | C20H17BrN6O2 | 853029-57-9 | Details |
| 7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine | C18H17F6N5O2 | 1379666-94-0 | Details |
| N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine | C20H25N5 | 1252883-90-1 | Details |
| 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | C6H4ClN3 | 3680-69-1 | Details |
| 4-[(5-Methyl-3-phenyl-4-isoxazolyl)methyl]benzenesulfonyl chloride | C17H14ClNO3S | 1391051-82-3 | Details |
| 2-MERCAPTO-5-METHOXYBENZIMIDAZOLE | C8H8N2OS | 37052-78-1 | Details |
| Pidotimod | C9H12N2O4S | 121808-62-6 | Details |
| 4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile | C20H23FN2O2 | 103146-25-4 | Details |
| Sitagliptin | C16H15F6N5O | 486460-32-6 | Details |
| (R)-3-(3-fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one | C16H21BFNO5 | 504438-22-6 | Details |
| PARECOXIB SODIUM | C19H19N2NaO4S | 198470-85-8 | Details |
| Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
| (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | C11H18N2O3 | 361440-67-7 | Details |
| pidotiMod iMpurity E | C9H12N2O4S | 162148-16-5 | Details |
| 2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine | C13H18BN5O2 | 1056039-83-8 | Details |
| Escitalopram | C20H21FN2O | 128196-01-0 | Details |
| N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C13H19N5 | 477600-74-1 | Details |
| 4-[(5-Methyl-3-phenyl-4-isoxazolyl)methyl]benzenesulfonamide | C17H16N2O3S | 1391052-01-9 | Details |
| BOC-(R)-3-AMINO-4-(2-FLUORO-PHENYL)-BUTYRIC ACID | C15H20FNO4 | 218608-98-1 | Details |
| (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | C7H9ClN2O | 207557-35-5 | Details |
| PALONOSETRON HCL | C19H24N2O | 135729-75-8 | Details |
| Valdecoxib IMpurity D | C16H13NO4S | 181696-35-5 | Details |
| Sitagliptin Defuoro IMpurity 3 | C15H19F2NO4 | 851307-12-5 | Details |
| L-carnitine | C7H15NO3 | 541-15-1 | Details |
| Ufiprazole | C17H19N3O2S | 73590-85-9 | Details |
| Citalopram | C20H21FN2O | 59729-33-8 | Details |
| Boc-3-Hydroxy-1-adamantyl-D-glycine | C17H27NO5 | 361442-00-4 | Details |
| 1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro- | C9H10N2O3S | 161771-76-2 | Details |
| D-(+)-Camphoric acid | C10H16O4 | 124-83-4 | Details |
| 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | C16H20N6O | 1092578-46-5 | Details |
| (2S)-1-{[(1-aMino-2-Methylpropan-2-yl)aMino]acetyl}pyrrolidine-2-carbonitrile Hydrochloride | C11H20N4O | 794460-89-2 | Details |
| Tedizolid Phosphate | C17H16FN6O6P | 856867-55-5 | Details |
| (5R)-3-(4-BROMO-3-FLUOROPHENYL)-5-HYDROXYMETHYLOXAZOLIDIN-2-ONE | C10H9BrFNO3 | 444335-16-4 | Details |
| Glycopyrrolate | C19H28BrNO3- | 596-51-0 | Details |
| Esomeprazole magnesium | C34H36MgN6O6S2 | 161973-10-0 | Details |
| Pramipexole Impurity 16 | C10H18ClN3S | 104632-27-1 | Details |
| (3-Carbamoylallyl)trimethylammonium | C7H15N2O+ | 857162-57-3 | Details |
| Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | C15H18F3NO4 | 486460-00-8 | Details |
| AGOMELATINE | C15H17NO2 | 138112-76-2 | Details |
| [(±)-(4-amino-2-hydroxy-4-oxobutyl)trimethylammonium] chloride | C7H18ClN2O2+ | 5261-99-4 | Details |
| Glycopyrronium Bromide | C19H28NO3.Br | 51186-83-5 | Details |
| Tofacitinib citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| pidotiMod iMpurity D | C9H12N2O4S | 162148-15-4 | Details |
| Vildagliptin (2R)-Isomer | C17H25N3O2 | 1036959-27-9 | Details |
| (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine | C14H22N2 | 477600-70-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||